title: [How I explore...the revisited toxic path of scleroderma].
abstract: The name scleroderma is given to a spectrum of diseases which differ clinically and bear different prognostic risks. The origins of the various forms of the disease are unclear. A toxic influence has been suggested, particularly for the progressive systemic scleroderma. However, the imputability of the suspected chemicals often remains unsettled.
authors.affiliation: CHU du Sart Tilman, Service de Dermatopathologie, Liège, Belgique. pascale.quatresooz@chu.ulg.ac.be
authors.forename: P
authors.initials: P
authors.lastname: Quatresooz
authors.forename: P
authors.initials: P
authors.lastname: Paquet
authors.forename: C
authors.initials: C
authors.lastname: Piérard-Franchimont
authors.forename: G E
authors.initials: GE
authors.lastname: Piérard
mesh_terms: D001323:Autoantibodies / Q000097:blood; D015415:Biomarkers / Q000097:blood; D003937:Diagnosis, Differential; D006801:Humans; D006841:Hydrocarbons, Aromatic / Q000009:adverse effects; D011379:Prognosis; D045743:Scleroderma, Diffuse / Q000139:chemically induced; D012594:Scleroderma, Localized / Q000139:chemically induced; D012595:Scleroderma, Systemic / Q000097:blood / Q000139:chemically induced* / Q000473:pathology; D012822:Silicon Dioxide / Q000009:adverse effects*
chemical_list: D001323:Autoantibodies; D015415:Biomarkers; D006841:Hydrocarbons, Aromatic; D012822:Silicon Dioxide